Skip to content

Drug interactions

Panobinostat + Ziprasidone

Severity: Contraindicated

Panobinostat and Ziprasidone: contraindicated interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Panobinostat prolongs the QT interval and ziprasidone has the same effect. Together they raise the risk of torsades de pointes, and panobinostat labeling advises against using it with QT-prolonging drugs.

What this interaction means in plain words

Panobinostat and Ziprasidone are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two.

Panobinostat belongs to Oncology; Ziprasidone belongs to Central Nervous System.

Evidence level: Moderate

Why it happens

Additive delayed cardiac repolarization through hERG channel inhibition and altered ion channel function.

What to do

Do not combine them; choose an antipsychotic with a lower QT liability. If panobinostat therapy is essential, review the psychiatric regimen with the prescriber before starting it.

What to ask your pharmacist

  • Is there an alternative to one of these two medicines for me?
  • If both are essential, who is monitoring me and how often?
  • Which symptoms mean I should stop and seek help straight away?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Panobinostat and Ziprasidone, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Panobinostat with Ziprasidone?

MediHelp rates the interaction as contraindicated. Panobinostat and Ziprasidone are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two. Panobinostat prolongs the QT interval and ziprasidone has the same effect. Together they raise the risk of torsades de pointes, and panobinostat labeling advises against using it with QT-prolonging drugs.

How serious is the interaction between Panobinostat and Ziprasidone?

MediHelp rates it contraindicated, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Do not combine them; choose an antipsychotic with a lower QT liability. If panobinostat therapy is essential, review the psychiatric regimen with the prescriber before starting it.

What other medicines interact with Ziprasidone?

MediHelp also lists interactions of Ziprasidone with, for example, Amiodarone, Amitriptyline, Arsenic trioxide. The full list is on the Ziprasidone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in